glp-1 masld Effect of pemvidutide, a GLP-1/glucagon dual receptor agonist, on MASLD: A randomized, double-blind, placebo-controlled study Incretin-based therapies in MASLD/MASH: from

Bananas (unripe)

Packer M, Zile MR, Kramer CM, Baum SJ, Litwin SE, Menon V, et al

Why Protein Becomes Critical During GLP-1 Therapy Prioritizing protein helps preserve muscle tissue and supports metabolic health during weight loss

Ozempic: the truth about new weight-loss drugs Wegovy study finds weight-loss drug sharply cuts heart attacks, strokes and cardiac deaths What to do about fake weight-loss drugs and compounded versions Nutrition is vital when taking GLP-1 weight-loss drugs

Food quality, meal timing, movement, sleep, and stress regulation all matter

Nausea is the most commonly reported side effect, followed by constipation, stomach pain, diarrhea, fatigue, and vomiting